Please login to the form below

Not currently logged in

baloxavir marboxil

This page shows the latest baloxavir marboxil news and features for those working in and with pharma, biotech and healthcare.

Roche’s influenza medicine approved by EC for children

Roche’s influenza medicine approved by EC for children

Roche’s Xofluza (baloxavir marboxil) has been approved by the European Commission (EC) to treat and prevent uncomplicated influenza in children aged one year and over.

Latest news

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Subscribe to our email news alerts


Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

The speed of science and the pace of comms
Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
Improving cardiovascular disease care and awareness
Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......